Mostrar el registro sencillo del ítem

dc.contributor.authorGutiérrez-Aroca, Juan-Bautista
dc.contributor.authorRuiz, Pilar
dc.contributor.authorVaquero Abellán, Manuel
dc.contributor.authorCausse, Manuel
dc.contributor.authorCasal Román, Manuel
dc.date.accessioned2018-12-21T11:49:48Z
dc.date.available2018-12-21T11:49:48Z
dc.date.issued2018
dc.identifier.urihttp://hdl.handle.net/10396/17611
dc.description.abstractMultidrug-resistant (MDR) tuberculosis (TB) is a cause of increasing concern. This study investigated first-line anti-TB drug resistance in Mycobacterium tuberculosis strains submitted to the Tuberculosis Reference Center in Co´rdoba (Spain) between 2001 and 2015. A total of 1,207 cultures were tested against first-line drugs using the BACTEC MGIT 960 system. Resistance to first-line drugs was detected in 207 strains (17.2%), the greatest resistance being found in INH (5.3%) followed by streptomycin (3%), pyrazinamide (2.2%), rifampicin (1%), and ethambutol (0.2%). A total of 1.9% of strains were MDR. Six strains displayed resistance to four drugs, and three strains to five drugs. In view of resistance observed, careful surveillance of drug resistance is recommendedes_ES
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMary Ann Liebert, Inc.es_ES
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.sourceMicrobial Drug Resistance (2018)es_ES
dc.subjectTuberculosises_ES
dc.subjectResistancees_ES
dc.subjectMycobacteriumes_ES
dc.titleSurveillance of Drug-Resistant Tuberculosis in Spain (2001–2015)es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.1089/mdr.2017.0353es_ES
dc.relation.projectIDGobierno de España. REIPI RD06/0008es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem